Choose Your Country or Region

Mezagitamab (Anti-CD38)

Synonyms: TAK-079

Catalog No.A2819 Purity: 99%

Mezagitamab (Anti-CD38) is a human, non-agonistic immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein ADP-ribosyl cyclase 1 (CD38) with potential immunomodulating and antineoplastic activities. MW : 144.44 KD.

Mezagitamab (Anti-CD38)

Purity & Quality Control

Batch: A281901 Purity: 99% Protein concentration: 3.87mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Mezagitamab (Anti-CD38) is a human, non-agonistic immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein ADP-ribosyl cyclase 1 (CD38) with potential immunomodulating and antineoplastic activities. MW : 144.44 KD.

References

[1] Abadier M, et al. Blood (2020) 136 (Supplement 1) : 9.

Product Details

CAS No.	2227490-52-8
Molecular Weight	144.44
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Tags: buy Mezagitamab (Anti-CD38) | Mezagitamab (Anti-CD38) supplier | purchase Mezagitamab (Anti-CD38) | Mezagitamab (Anti-CD38) cost | Mezagitamab (Anti-CD38) manufacturer | order Mezagitamab (Anti-CD38) | Mezagitamab (Anti-CD38) distributor

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID